Evidence map›Paper›PMID 32770717›Full record

SynthesisDermatologic therapy2020

Cutaneous, skin histopathological manifestations and relationship to COVID-19 infection patients.

Hongxin Li, Yong Zhao, Lin Zhou, Jin Hu

Open access · greenAbstract readSystematic Review
In one paragraph

Synthesis in Dermatologic therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Toxic erythema as the first sign of COVID-19 infection.Clinical and experimental dermatology · 2021
    Article
  8. Review
  9. Article
  10. Comparison of COVID-19 and influenza characteristics.Journal of Zhejiang University. Science. B · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Hongxin LiDepartment of Dermatology, Children's Hospital Affiliated to Capital Institute of Pediatrics, Beijing, China.ORCID 0000-0001-9377-722X
Yong ZhaoThe Sixth Medical Centre of PLA, General Hospital, Beijing, China.
Lin ZhouDepartment of Clinical Laboratory, Children's Hospital Affiliated to Capital Institute of Pediatrics, Beijing, China.
Jin HuDepartment of Dermatology, Children's Hospital Affiliated to Capital Institute of Pediatrics, Beijing, China.
Capital Institute of Pediatrics · CNChinese PLA General Hospital · CN

Funding

Research Foundation of Capital Institute of Pediatrics PY-2020-05
6 · The paper itself

Abstract

COVID-19 diseases have been a nationwide pandemic condition. However, cutaneous, skin histopathological manifestations of COVID-19 infection are not well described. Our study aims are to present heterogeneous cutaneous, histopathological manifestations in COVID-19 patients, to investigate the possible relationship between cutaneous manifestations and histopathological features in COVID-19 infection. We performed a systemic review in PubMed database and Chinese medical journal search engines which were wangfang.data (http://www.wanfangdata.com.cn/), Science China (http://www.cnki.net/) until June 17th, 2020. Search terms "COVID-19," "SARS-Coronavirus-2" and "Coronavirus" were used in combination with "cutaneous," "rash," "skin," "dermatology." Seventy-five papers were included with confirmed COVID-19 infection. The most frequent cutaneous manifestation of COVID-19 present was erythema, nearly 38.4%. Trunk was the most affected location, presenting in 51.4% patients. Rash occurred before onset of other symptoms was in 5.3% patients. Seventy-seven patients were received treatments. Rash was dismissed in 49% patients, improved in 21.2% patients ranged from 0 to 17 days. The histopathological examination present in 39 patients. Skin is one of target organs affected by COVID-19 infection. Cutaneous manifestations should be paid more attention. It can help doctors diagnose COVID-19 infection in prodromal stage, understand progression, and determine prognosis of COVID-19 infection.

Indexed as

COVID-19 TestingCOVID-19Disease ProgressionHumansPrognosisSkin Diseases, ViralCOVID-19cutaneous manifestationshistopathologySARS-CoV-2

Identifiers

PMID32770717
PMCPMC7435499
OpenAlexW3048095124

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.